These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16446007)

  • 1. Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD.
    Santo SS; Sergio N; Luigi DP; Giuseppe M; Margherita F; Gea OC; Roberto F; Gabriella C; Giuseppe P; Massimiliano A
    Diabetes Res Clin Pract; 2006 Jun; 72(3):231-7. PubMed ID: 16446007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.
    Signorelli SS; Fatuzzo P; Rapisarda F; Neri S; Ferrante M; Oliveri Conti G; Fallico R; Di Pino L; Pennisi G; Celotta G; Massimiliano A
    Drugs Aging; 2006; 23(3):263-70. PubMed ID: 16608381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of propionyl-L-carnitine in the treatment of diabetic angiopathy: controlled double blind trial versus placebo.
    Greco AV; Mingrone G; Bianchi M; Ghirlanda G
    Drugs Exp Clin Res; 1992; 18(2):69-80. PubMed ID: 1644013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease.
    Signorelli SS; Fatuzzo P; Rapisarda F; Neri S; Ferrante M; Oliveri Conti G; Fallico R; Di Pino L; Pennisi G; Celotta G; Anzaldi M
    Kidney Blood Press Res; 2006; 29(2):100-7. PubMed ID: 16809937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vascular and biochemical effects of cilostazol in diabetic patients with peripheral arterial disease.
    O'Donnell ME; Badger SA; Sharif MA; Makar RR; Young IS; Lee B; Soong CV
    Vasc Endovascular Surg; 2009; 43(2):132-43. PubMed ID: 19131370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication.
    Luo T; Li J; Li L; Yang B; Liu C; Zheng Q; Jin B; Chen Z; Li K; Zhang X; Zhang J
    Thromb Res; 2013 Oct; 132(4):427-32. PubMed ID: 23998557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
    Morano S; Mandosi E; Fallarino M; Gatti A; Tiberti C; Sensi M; Gandini L; Buchetti B; Lenti L; Jannini EA; Lenzi A
    Eur Urol; 2007 Dec; 52(6):1768-74. PubMed ID: 17478034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
    Riccioni C; Sarcinella R; Palermo G; Izzo A; Liguori M; Koverech A; Messano M; Virmani A
    Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propionyl-L-carnitine improves endothelial function, microcirculation and pain management in critical limb ischemia.
    De Marchi S; Zecchetto S; Rigoni A; Prior M; Fondrieschi L; Scuro A; Rulfo F; Arosio E
    Cardiovasc Drugs Ther; 2012 Oct; 26(5):401-8. PubMed ID: 22936457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S; Longo A; Toon S; Rolan P; Evans AM
    Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM.
    Reaven PD; Herold DA; Barnett J; Edelman S
    Diabetes Care; 1995 Jun; 18(6):807-16. PubMed ID: 7555507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease.
    O'Donnell ME; Badger SA; Sharif MA; Young IS; Lee B; Soong CV
    J Vasc Surg; 2009 May; 49(5):1226-34. PubMed ID: 19217745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.
    McDermott MM; Liu K; Greenland P; Guralnik JM; Criqui MH; Chan C; Pearce WH; Schneider JR; Ferrucci L; Celic L; Taylor LM; Vonesh E; Martin GJ; Clark E
    JAMA; 2004 Jul; 292(4):453-61. PubMed ID: 15280343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.
    Mikhailova TL; Sishkova E; Poniewierka E; Zhidkov KP; Bakulin IG; Kupcinskas L; Lesniakowski K; Grinevich VB; Malecka-Panas E; Ardizzone S; D'Arienzo A; Valpiani D; Koch M; Denapiene G; Vago G; Fociani P; Zerbi P; Ceracchi M; Camerini R; Gasbarrini G
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1088-97. PubMed ID: 21929562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone use in combination with insulin in the prospective pioglitazone clinical trial in macrovascular events study (PROactive19).
    Charbonnel B; DeFronzo R; Davidson J; Schmitz O; Birkeland K; Pirags V; Scheen A;
    J Clin Endocrinol Metab; 2010 May; 95(5):2163-71. PubMed ID: 20237169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.
    Lirussi F; Beccarello A; Zanette G; De Monte A; Donadon V; Velussi M; Crepaldi G
    Diabetes Nutr Metab; 2002 Aug; 15(4):222-31. PubMed ID: 12416659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients.
    Clairotte C; Retout S; Potier L; Roussel R; Escoubet B
    Diabetes Care; 2009 Jul; 32(7):1231-6. PubMed ID: 19366974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.